Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nasopharyngeal Cancer Recurrent”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04547088
What this trial is testing

Camrelizumab Combined With Apatinib in Patients With First-line Platinum-resistant Recurrent/Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 27
Testing effectiveness (Phase 2)Study completedNCT00063895
What this trial is testing

Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Recurrent Non-small Cell Lung CancerRecurrent Ovarian Epithelial CancerRecurrent Squamous Cell Carcinoma of the Hypopharynx+27 more
National Cancer Institute (NCI) 80
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)UnknownNCT05350891
What this trial is testing

Transnasal Endoscopic Surgery Combined With Adjuvant Immunotherapy for Recurrent NPC

Who this might be right for
Recurrent Nasopharyngeal Carcinoma
Eye & ENT Hospital of Fudan University 77
Testing effectiveness (Phase 2)UnknownNCT00003182
What this trial is testing

Cisplatin and Gemcitabine in Treating Patients With Advanced Squamous Cell Cancer of the Head and Neck

Who this might be right for
Head and Neck Cancer
Hope Cancer Institute, Inc. 40
Testing effectiveness (Phase 2)Looking for participantsNCT06980038
What this trial is testing

Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer

Who this might be right for
Head and Neck Squamous Cell CarcinomaHypopharyngeal Squamous Cell CarcinomaLaryngeal Squamous Cell Carcinoma+19 more
National Cancer Institute (NCI) 44
Not applicableLooking for participantsNCT00898638
What this trial is testing

Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants

Who this might be right for
Head and Neck Cancer
Vanderbilt University Medical Center 8,000
Testing effectiveness (Phase 2)Ended earlyNCT05721222
What this trial is testing

Trial of PRO1160 (GEN1160) in Relapsed or Refractory Non-Hodgkin Lymphoma (NHL) (PRO1160-001)

Who this might be right for
Renal Cell CarcinomaNasopharyngeal CarcinomaNon Hodgkin Lymphoma
Genmab 42
Not applicableLooking for participantsNCT06389201
What this trial is testing

Pretreatment With HCQ Before Radiotherapy and Chemotherapy in Advanced NPC Patients

Who this might be right for
Nasopharyngeal Carcinoma
Affiliated Hospital of Nantong University 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT05513573
What this trial is testing

Phase II Clinical Study to Compare the Efficacy and Safety of HLX07 + Serplulimab +Chemotherapy Versus Placebo + Serplulimab + Chemotherapy in First-Line Treatment of Patients With Recurrent or Metastatic NPC

Who this might be right for
Nasopharyngeal Carcinoma by AJCC V8 Stage
Shanghai Henlius Biotech 75
Testing effectiveness (Phase 2)UnknownNCT03130270
What this trial is testing

Maintenance Treatment of Apatinib in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Guilin Medical University, China 29
Large-scale testing (Phase 3)Study completedNCT00004234
What this trial is testing

Oral Mucositis in Patients Receiving Radiation Therapy for Cancer of the Mouth, Pharynx, or Larynx

Who this might be right for
Head and Neck CancerOral Complications
NCIC Clinical Trials Group
Not applicableLooking for participantsNCT04425265
What this trial is testing

Plasma Radiofrequency Ablation at Low Temperature Versus Electrocautery Block Resection at High Frequency for Localized Recurrent Nasopharyngeal Carcinoma

Who this might be right for
SurgeryRecurrent Nasopharyngeal Carcinoma
Sun Yat-sen University 500
Early research (Phase 1)Study completedNCT00629226
What this trial is testing

Bortezomib, Cetuximab, and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage IV Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
National Cancer Institute (NCI) 46
Testing effectiveness (Phase 2)Study completedNCT00021333
What this trial is testing

Paclitaxel and Cisplatin Plus Radiation Therapy Followed by Filgrastim in Treating Patients With Recurrent Head and Neck Cancer or Lung Cancer

Who this might be right for
Head and Neck CancerLung Cancer
Fox Chase Cancer Center 29
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06987123
What this trial is testing

TC as Adjuvant Therapy After Surgery for Locally Recurrent Resectable Nasopharyngeal Carcinoma: a Single-arm Clinical Trial

Who this might be right for
Nasopharyngeal Carcinoma (NPC)
Sun Yat-sen University 62
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07129772
What this trial is testing

Perioperative Chemotherapy and Immunotherapy for Locally Recurrent Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Cancer RecurrentNasopharyngeal Cancinoma (NPC)
The University of Hong Kong 53
Testing effectiveness (Phase 2)Ended earlyNCT02706691
What this trial is testing

BGJ398 in Treating Patients With FGFR Positive Recurrent Head and Neck Cancer

Who this might be right for
FGFR Gene AmplificationFGFR1 Gene AmplificationFGFR2 Gene Amplification+7 more
University of Chicago 1
Early research (Phase 1)WithdrawnNCT00937417
What this trial is testing

S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors

Who this might be right for
Breast CancerHead and Neck CancerLung Cancer+2 more
SWOG Cancer Research Network
Testing effectiveness (Phase 2)Active Not RecruitingNCT05126719
What this trial is testing

Evaluate the Efficacy and Safety of MRG003 in Patients With Recurrent Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Recurrent or Metastatic Nasopharyngeal Carcinoma
Lepu Biopharma Co., Ltd. 238
Next Page